Brought to you by:
![Vascular Specialist [LIVE]](https://vascularspecialistonline.com/wp-content/uploads/2026/08/vascular_specialist_logo_forwebsite_new.png){kind=logo}
Optimizing acute limb ischemia treatment with a percutaneous-first approach
This advertorial is sponsored by Penumbra. Acute limb ischemia (ALI) management is evolving as new thrombectomy technologies expand the role of endovascular intervention. Jayer Chung, MD, Professor and Medical Director in the Division of Vascular Surgery and Endovascular Therapy at…
Beyond the procedure: Rethinking long-term AVF success with VasQ
This advertorial is sponsored by Laminate Medical. What happens after a fistula is created can be just as important as the procedure itself. Dion Franga, MD, shares how innovations like VasQ may help improve fistula maturation, reduce catheter time and…
Advancing below-the-knee intervention in CLTI with Shockwave Javelin Peripheral IVL
This advertorial is sponsored by Shockwave Medical. Charles Bailey, MD, George Adams, MD and Vanessa Adams, BS, share their experience with Shockwave Javelin, the first-of-its-kind forward intravascular lithotripsy (IVL) technology that is enabling further interventional treatment for patients suffering from…
New lower extremity revascularization CPT codes include physician payment for intravascular lithotripsy
This advertorial is sponsored by Shockwave Medical. A major overhaul of current procedural terminology (CPT) coding for lower extremity revascularization (LER) took effect in January, introducing new codes and allowing physicians to receive dedicated work relative value unit (wRVU) credit for the use of intravascular…
Stent maintenance: Sustaining long-term patency in deep venous system
This advertorial is sponsored by Stryker/Inari Medical. As venous stenting becomes more common, the focus must now shift to what occurs after the procedure, according to consultant vascular surgeon Stephen Black, MD, FRCS. The concept of stent maintenance is key,…
Esprit BTK: Drug-eluting resorbable scaffold poised as first-line therapy for below-the-knee CLTI
This advertorial is sponsored by Abbott. “We now have something on label and FDA [Food and Drug Administration] approved that we can use as a first-line therapy for tibial vessels,” Richard Pin, MD, chief of vascular surgery at Southcoast Health…